| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 2.54e-05 | 31 | 37 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 3.33e-05 | 5 | 37 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.31e-05 | 129 | 37 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.71e-04 | 151 | 37 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 5.02e-04 | 18 | 37 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.58e-03 | 465 | 37 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.70e-03 | 33 | 37 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 2.20e-03 | 140 | 37 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.61e-03 | 343 | 37 | 4 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium channel activity | 4.18e-03 | 52 | 37 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.04e-03 | 188 | 37 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 5.42e-03 | 193 | 37 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 5.70e-03 | 627 | 37 | 5 | GO:0022890 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 5.74e-03 | 197 | 37 | 3 | GO:0022834 | |
| GeneOntologyBiologicalProcess | G1 to G0 transition involved in cell differentiation | 4.68e-05 | 6 | 37 | 2 | GO:0070315 | |
| Domain | G2F | 1.21e-05 | 3 | 38 | 2 | SM00682 | |
| Domain | GFP | 2.41e-05 | 4 | 38 | 2 | IPR009017 | |
| Domain | G2F | 2.41e-05 | 4 | 38 | 2 | PF07474 | |
| Domain | G2_nidogen/fibulin_G2F | 2.41e-05 | 4 | 38 | 2 | IPR006605 | |
| Domain | NIDOGEN_G2 | 2.41e-05 | 4 | 38 | 2 | PS50993 | |
| Domain | - | 2.19e-04 | 11 | 38 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 2.19e-04 | 11 | 38 | 2 | IPR023413 | |
| Domain | PKD1_2_channel | 2.19e-04 | 11 | 38 | 2 | IPR013122 | |
| Domain | PKD_channel | 2.19e-04 | 11 | 38 | 2 | PF08016 | |
| Domain | cEGF | 1.27e-03 | 26 | 38 | 2 | IPR026823 | |
| Domain | cEGF | 1.27e-03 | 26 | 38 | 2 | PF12662 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.47e-03 | 28 | 38 | 2 | IPR004843 | |
| Domain | Metallophos | 1.47e-03 | 28 | 38 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 1.69e-03 | 30 | 38 | 2 | IPR029052 | |
| Domain | - | 1.69e-03 | 30 | 38 | 2 | 3.60.21.10 | |
| Domain | TPR_8 | 5.20e-03 | 53 | 38 | 2 | PF13181 | |
| Pubmed | Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1. | 1.16e-06 | 2 | 38 | 2 | 18199826 | |
| Pubmed | 1.16e-06 | 2 | 38 | 2 | 25450682 | ||
| Pubmed | 4.31e-06 | 29 | 38 | 3 | 22613833 | ||
| Pubmed | 6.96e-06 | 4 | 38 | 2 | 36007682 | ||
| Pubmed | 2.31e-05 | 152 | 38 | 4 | 11044609 | ||
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 6.35e-05 | 11 | 38 | 2 | 38303699 | |
| Pubmed | 1.38e-04 | 16 | 38 | 2 | 15878328 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.86e-04 | 101 | 38 | 3 | 20551380 | |
| Pubmed | 5.65e-04 | 32 | 38 | 2 | 23154389 | ||
| Pubmed | 6.01e-04 | 33 | 38 | 2 | 19834762 | ||
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 6.38e-04 | 34 | 38 | 2 | 20834067 | |
| Pubmed | 8.83e-04 | 40 | 38 | 2 | 27197753 | ||
| Pubmed | 9.28e-04 | 175 | 38 | 3 | 28071719 | ||
| Pubmed | 1.07e-03 | 44 | 38 | 2 | 19322198 | ||
| Cytoband | 13q34 | 9.29e-04 | 54 | 38 | 2 | 13q34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 2.44e-03 | 88 | 38 | 2 | chr13q34 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.36e-02 | 115 | 28 | 2 | 769 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP | 3.77e-07 | 197 | 38 | 6 | M5378 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 3.62e-05 | 261 | 38 | 5 | M1834 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | 5.96e-05 | 290 | 38 | 5 | M939 | |
| Coexpression | HORIUCHI_WTAP_TARGETS_UP | 8.04e-05 | 309 | 38 | 5 | M1973 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 9.24e-05 | 164 | 38 | 4 | M41676 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 1.01e-04 | 168 | 38 | 4 | M7007 | |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN | 1.21e-04 | 337 | 38 | 5 | M13206 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_100 | 2.08e-05 | 30 | 38 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_200 | 2.78e-05 | 33 | 38 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#2_top-relative-expression-ranked_200 | 5.78e-05 | 42 | 38 | 3 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k2_200 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_200 | 6.17e-05 | 120 | 38 | 4 | gudmap_kidney_P1_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_top-relative-expression-ranked_200 | 7.01e-05 | 124 | 38 | 4 | gudmap_kidney_P0_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 1.62e-04 | 291 | 38 | 5 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_top-relative-expression-ranked_100 | 1.86e-04 | 62 | 38 | 3 | gudmap_kidney_P1_CapMes_Crym_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.17e-04 | 310 | 38 | 5 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 2.41e-04 | 317 | 38 | 5 | GSM538412_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.15e-04 | 336 | 38 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_100 | 3.95e-04 | 80 | 38 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_100 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_100 | 4.56e-04 | 84 | 38 | 3 | gudmap_kidney_P2_CapMes_Crym_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#4_top-relative-expression-ranked_100 | 4.69e-04 | 18 | 38 | 2 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k4_100 | |
| CoexpressionAtlas | Stem Cells, SC.MPP34F.BM, Lineage- cKit+ Sca-1+ flk2+ CD34+, Bone marrow, avg-2 | 4.72e-04 | 85 | 38 | 3 | GSM791110_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 4.99e-04 | 207 | 38 | 4 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_200 | 5.23e-04 | 19 | 38 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_200 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.17e-07 | 193 | 38 | 5 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 6.17e-07 | 193 | 38 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.17e-07 | 193 | 38 | 5 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.17e-07 | 193 | 38 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 6.17e-07 | 193 | 38 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.17e-07 | 193 | 38 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-07 | 194 | 38 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.33e-07 | 194 | 38 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 6.49e-07 | 195 | 38 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.49e-07 | 195 | 38 | 5 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-07 | 196 | 38 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-07 | 196 | 38 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.83e-07 | 197 | 38 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.83e-07 | 197 | 38 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.83e-07 | 197 | 38 | 5 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.83e-07 | 197 | 38 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-07 | 198 | 38 | 5 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 7.00e-07 | 198 | 38 | 5 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.00e-07 | 198 | 38 | 5 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.00e-07 | 198 | 38 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.00e-07 | 198 | 38 | 5 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.18e-07 | 199 | 38 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.18e-07 | 199 | 38 | 5 | fb23ecce41e31e2cc01814e3c0add756f489561f | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 7.18e-07 | 199 | 38 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.18e-07 | 199 | 38 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.18e-07 | 199 | 38 | 5 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.18e-07 | 199 | 38 | 5 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.36e-07 | 200 | 38 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 200 | 38 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 7.36e-07 | 200 | 38 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.36e-07 | 200 | 38 | 5 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 1.22e-05 | 167 | 38 | 4 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.28e-05 | 169 | 38 | 4 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-05 | 173 | 38 | 4 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 179 | 38 | 4 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.61e-05 | 179 | 38 | 4 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-05 | 181 | 38 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | facs-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 182 | 38 | 4 | 45faefd7cbeac84d2c58650530b902af6ce921f8 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.72e-05 | 182 | 38 | 4 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-05 | 184 | 38 | 4 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 184 | 38 | 4 | fea4fe648e9749177d0783443dc26a7df5807883 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-05 | 184 | 38 | 4 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 184 | 38 | 4 | 96a8a0a190bc293655fe7d80cbed8119c0da25f2 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 184 | 38 | 4 | 780eb72da43527f0c72effac3423ec7384f05f20 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-05 | 185 | 38 | 4 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.83e-05 | 185 | 38 | 4 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.83e-05 | 185 | 38 | 4 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 186 | 38 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.87e-05 | 186 | 38 | 4 | 8ea708070166c858cd9bd871670655b0114c32a5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 187 | 38 | 4 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.91e-05 | 187 | 38 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.91e-05 | 187 | 38 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-05 | 189 | 38 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.99e-05 | 189 | 38 | 4 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.03e-05 | 190 | 38 | 4 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.03e-05 | 190 | 38 | 4 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.03e-05 | 190 | 38 | 4 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.03e-05 | 190 | 38 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 38 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 38 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-05 | 191 | 38 | 4 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.08e-05 | 191 | 38 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.08e-05 | 191 | 38 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.08e-05 | 191 | 38 | 4 | 997abf0cc5873bed0372c4a333ed307fa72774d2 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-05 | 191 | 38 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-05 | 191 | 38 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-05 | 192 | 38 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.12e-05 | 192 | 38 | 4 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.16e-05 | 193 | 38 | 4 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.16e-05 | 193 | 38 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 194 | 38 | 4 | d9eec28fa7b255c0ec023276dd955f1e276e7159 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 194 | 38 | 4 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.21e-05 | 194 | 38 | 4 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.21e-05 | 194 | 38 | 4 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.21e-05 | 194 | 38 | 4 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 194 | 38 | 4 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-05 | 194 | 38 | 4 | e4d7e9709ce42d4610e44d3445927eefbcbb9eff | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 2.25e-05 | 195 | 38 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 195 | 38 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 195 | 38 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.25e-05 | 195 | 38 | 4 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 195 | 38 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 195 | 38 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 196 | 38 | 4 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.30e-05 | 196 | 38 | 4 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 2.30e-05 | 196 | 38 | 4 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 196 | 38 | 4 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-05 | 196 | 38 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.30e-05 | 196 | 38 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.30e-05 | 196 | 38 | 4 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.30e-05 | 196 | 38 | 4 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 196 | 38 | 4 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.30e-05 | 196 | 38 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.30e-05 | 196 | 38 | 4 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-05 | 197 | 38 | 4 | d5d9263451f6c10cb3b9c17740183ca334e24851 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-G|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.34e-05 | 197 | 38 | 4 | 156155c2f0c1a2461e45803da578af18ee221660 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-05 | 197 | 38 | 4 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-05 | 197 | 38 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.34e-05 | 197 | 38 | 4 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 1.57e-05 | 196 | 37 | 5 | 7513_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.60e-05 | 197 | 37 | 5 | 4771_DN | |
| Drug | gadolinium | 1.68e-05 | 199 | 37 | 5 | CID000023982 | |
| Disease | fibrinogen measurement | 3.20e-04 | 109 | 36 | 3 | EFO_0004623 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.39e-03 | 45 | 36 | 2 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.39e-03 | 45 | 36 | 2 | EFO_0004623, EFO_0004792 | |
| Disease | Cirrhosis | 1.71e-03 | 50 | 36 | 2 | C1623038 | |
| Disease | Fibrosis | 1.71e-03 | 50 | 36 | 2 | C0016059 | |
| Disease | lobe attachment | 2.05e-03 | 207 | 36 | 3 | EFO_0007667 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 2.14e-03 | 56 | 36 | 2 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | fibrinogen measurement, factor VII measurement | 2.29e-03 | 58 | 36 | 2 | EFO_0004619, EFO_0004623 | |
| Disease | Liver Cirrhosis, Experimental | 2.36e-03 | 774 | 36 | 5 | C0023893 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 2.45e-03 | 60 | 36 | 2 | C4722327 | |
| Disease | Prostate cancer, familial | 3.23e-03 | 69 | 36 | 2 | C2931456 | |
| Disease | aortic measurement | 3.53e-03 | 251 | 36 | 3 | EFO_0020865 | |
| Disease | intellectual disability (implicated_via_orthology) | 3.80e-03 | 75 | 36 | 2 | DOID:1059 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGRYYNAHIQEVGNE | 506 | Q9NP73 | |
| EEQGGVGAFQYYQLH | 336 | Q9Y646 | |
| LDGIYQYGHIETNDN | 81 | P59827 | |
| QLGDIIDGYNAQYNA | 71 | Q3LIE5 | |
| YSQYDRFHIGNEKQN | 386 | Q15389 | |
| GANFLNNYLYDGEEI | 136 | P19835 | |
| IGNLAQQGHYDSYKQ | 131 | P55771 | |
| RDYDENEVDPYHGNQ | 4856 | Q9NU22 | |
| LYNVSVGNHAYENKG | 136 | Q8TDD5 | |
| NHEQLEGNERYEGYC | 441 | P42263 | |
| QHYYQLFDNDRTQLG | 16 | P61970 | |
| AHLGDLNQDGYNDIA | 391 | P53708 | |
| YLQINNADLGDTANY | 3676 | Q96RW7 | |
| DGNIQDEYGNTALHY | 231 | A0JP26 | |
| EQQQRHAQAQYAYPG | 941 | Q14112 | |
| YDNGHGVLEDNDIYN | 646 | Q86XK2 | |
| EGAGHNDIELYAQYL | 301 | Q6PCB6 | |
| QLLDDGNGENYVDYA | 1591 | P20908 | |
| ENFTGNQYVLEEGHY | 1461 | Q9Y4K1 | |
| NGGDIRYHIYNVNEE | 271 | Q15835 | |
| VNDAGFHLNNQLYDI | 751 | P20807 | |
| ENYQAGGSENYHELL | 86 | Q96KW9 | |
| GNYIELNEENDFHYN | 396 | Q5U5Q3 | |
| DAHYERNGNNSHLYQ | 146 | Q7Z443 | |
| TNNAQNGHLLEDDYY | 1906 | Q9HCD6 | |
| QHGDYQYGRNNILTD | 376 | Q96K37 | |
| QNHYLAQLFGLYGEN | 36 | Q6ZMH5 | |
| ELQQFQHEGKIYEYN | 151 | Q9H7R5 | |
| DANYGELQEHKAQAY | 131 | Q8TAG5 | |
| DHNLQYLQDENGVGY | 241 | P13686 | |
| YQEAAIYLQEGENND | 71 | Q9ULQ1 | |
| GEYDTALQYHQLDLQ | 1011 | Q96AY4 | |
| NHYAGYEQVTNEDLL | 121 | Q9NYA1 | |
| DRQDQSYHYGQPDGQ | 491 | Q6XPR3 | |
| FEQHQGQEEGYFRQL | 151 | Q8TAF7 | |
| GIYDNALDNDNYNLA | 1426 | P35573 | |
| QDGYRYNVNQLGDAH | 441 | Q92802 | |
| YLGEFGEDQIYEAHQ | 146 | Q8WU39 |